| AAZ | acetazolamide |
| Absorp. | absorption |
| ADMET | absorption, distribution, metabolism, excretion, and toxicity |
| AMP | ampicillin |
| BHI | brain hearth infusion |
| BRZ | brinzolamide |
| CA | carbonic anhydrase |
| cat. | catalyst |
| CLSI | Clinical and Laboratory Standards Institute |
| CNS | central neural system |
| Comp. | compound |
| DCP | dichlorphenamide |
| DMEM | Dulbecco’s modified Eagle medium |
| DMF | N,N-dimethylformamide |
| DMSO | dimethyl sulfoxide |
| DOX | doxorubicin |
| DZA | dorzolamide |
| E. faecalis | Enterococcus faecalis |
| E. faecium | Enterococcus faecium |
| EMA | European Medicines Agency |
| EZA | ethoxzolamide |
| FDA | Food and Drug Administration |
| FTIR | Fourier transform infrared spectroscopy |
| hCA | human carbonic anhydrase |
| HERG | human ether-a-go-go-related gene |
| IFD | induced-fit docking |
| IND | indisulam |
| MD | molecular dynamic |
| MIC | minimum inhibitory concentration |
| MM/GBSA | molecular mechanics generalized Born surface area |
| MRSA | methicillin-resistant S. aureus |
| MTT | methylthiazolyldiphenyl-tetrazolium bromide |
| MZA | methazolamide |
| NMR | nuclear magnetic resonance |
| NT | not tested |
| PBC | periodic boundary conditions |
| PBS | phosphate buffered saline |
| PDB | protein data bank |
| PME | particle mesh Ewald |
| RMSD | root mean square deviation |
| S. aureus | Staphylococcus aureus |
| sp. | species |
| supp. | supported |
| TLC | thin-layer chromatography |
| TMS | tetramethylsilane |
| TOX | toxicity |
| VAN | vancomycin |
| VMD | visual molecular dynamics |
| VRE | vancomycin-resistant enterococci |
| WHO | World Health Organization |